Altered kynurenine pathway metabolites in serum of chronic migraine patients

Kynurenic acid modulates experimentally induced inflammation in the trigeminal ganglion

(2015) A. Csáti et al.   JOURNAL OF HEADACHE AND PAIN

Xanthurenic Acid Activates mGlu2/3 Metabotropic Glutamate Receptors and is a Potential Trait Marker for Schizophrenia

(2015) Francesco Fazio et al.   Scientific Reports

Chaos and commotion in the wake of cortical spreading depression and spreading depolarizations

(2014) Daniela Pietrobon et al.   NATURE REVIEWS NEUROSCIENCE

Cinnabarinic acid, an endogenous agonist of type-4 metabotropic glutamate receptor, suppresses experimental autoimmune encephalomyelitis in mice

(2014) Francesco Fazio et al.   NEUROPHARMACOLOGY

Migraine: the seventh disabler

(2013) Timothy J Steiner et al.   JOURNAL OF HEADACHE AND PAIN

Cortical spreading depression and migraine

(2013) Andrew C. Charles et al.   Nature Reviews Neurology

Modulation of Hippocampal Synaptic Transmission by the Kynurenine Pathway Member Xanthurenic Acid and Other VGLUT Inhibitors

(2013) S A Neale et al.   NEUROPSYCHOPHARMACOLOGY

Influence of Ovarian Hormones on Cortical Spreading Depression and Its Suppression by L-kynurenine in Rat

(2013) Virginie Chauvel et al.   PLoS One

Effect of systemic kynurenine on cortical spreading depression and its modulation by sex hormones in rat

(2012) Virginie Chauvel et al.   EXPERIMENTAL NEUROLOGY

Emerging treatment for chronic migraine and refractory chronic migraine

(2012) Luana Lionetto et al.   EXPERT OPINION ON EMERGING DRUGS

Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS)

(2012) L. M. Bloudek et al.   JOURNAL OF HEADACHE AND PAIN

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

(2012) Theo Vos et al.   LANCET

Kynurenines in the CNS: recent advances and new questions

(2012) László Vécsei et al.   NATURE REVIEWS DRUG DISCOVERY

Kynurenines in the mammalian brain: when physiology meets pathology

(2012) Robert Schwarcz et al.   NATURE REVIEWS NEUROSCIENCE

Meta-analysis of genome-wide association for migraine in six population-based European cohorts

(2011) Lannie Ligthart et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

The Global Campaign, World Health Organization and Lifting The Burden: collaboration in action

(2011) Timothy J. Steiner et al.   JOURNAL OF HEADACHE AND PAIN

Genome-wide association study reveals three susceptibility loci for common migraine in the general population

(2011) Daniel I Chasman et al.   NATURE GENETICS

From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment

(2011) Bita Moghaddam et al.   NEUROPSYCHOPHARMACOLOGY

Chronic migraine: comorbidities, risk factors, and rehabilitation

(2010) Andrea Negro et al.   Internal and Emergency Medicine

Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1

(2010) Verneri Anttila et al.   NATURE GENETICS

Metabotropic glutamate receptors: From the workbench to the bedside

(2010) F. Nicoletti et al.   NEUROPHARMACOLOGY

Transcriptional regulation of type-2 metabotropic glutamate receptors: an epigenetic path to novel treatments for chronic pain

(2010) Santina Chiechio et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Kynurenate Derivative Attenuates the Nitroglycerin-Induced CamKIIα and CGRP Expression Changes

(2009) Enikő Vámos et al.   HEADACHE

l-kynurenine combined with probenecid and the novel synthetic kynurenic acid derivative attenuate nitroglycerin-induced nNOS in the rat caudal trigeminal nucleus

(2009) Enikő Vámos et al.   NEUROPHARMACOLOGY

The kynurenate analog SZR-72 prevents the nitroglycerol-induced increase of c-fos immunoreactivity in the rat caudal trigeminal nucleus: Comparative studies of the effects of SZR-72 and kynurenic acid

(2008) E. Knyihar-Csillik et al.   NEUROSCIENCE RESEARCH